Structural zinc-binding protein

Structural zinc-binding proteins represent a vast and functionally diverse group of molecules where zinc ions are essential for maintaining the protein's three-dimensional architecture rather than participating directly in catalysis (PubMed: 12665801). The most prominent members are zinc finger proteins, which utilize zinc-coordinated loops to interact with DNA, RNA, and other proteins, making them critical regulators of gene expression and signal transduction (UniProt: Structural Zinc Binding). In many diseases, particularly cancer, the dysregulation of these proteins leads to aberrant transcriptional programs that drive tumor progression and metastasis (NCBI: PMC2829915). Therapeutically, these proteins are targeted through small molecules that eject the zinc ion, inhibitors that block their binding interfaces, or engineered zinc finger nucleases for precise genome editing (PubMed: 21606607). However, the high prevalence and structural similarity among different zinc-binding domains—estimated to be present in nearly 10% of the human proteome—pose significant challenges for achieving high selectivity and avoiding off-target effects (PubMed: 16431635). Understanding the specific coordination environment of the zinc ion is vital for developing next-generation drugs that can precisely modulate these essential biological components.

Other names

Zinc finger proteinZinc-binding domain-containing proteinStructural metalloproteinZinc-coordinated protein

Modulation of gene expression through DNA-binding inhibition, disruption of structural integrity via zinc chelation or ejection, or targeted genome editing.